resveratrol has been researched along with Hepatoblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, A; Bischoff, SC; Bitzer, M; Böcker, A; Busch, C; Lauer, UM; Leischner, C; Mayer, M; Noor, S; Schleicher, S; Venturelli, S; Weiland, T; Weiss, TS | 1 |
| Berlot, JP; Cherkaoui Malki, M; Delmas, D; Jannin, B; Latruffe, N; Passilly-Degrace, P | 1 |
| Delmas, D; Jannin, B; Lançon, A; Latruffe, N; Osman, H; Thénot, JP | 1 |
3 other study(ies) available for resveratrol and Hepatoblastoma
| Article | Year |
|---|---|
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
Topics: Acetylation; Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Computer Simulation; Hepatoblastoma; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Liver Neoplasms; Molecular Docking Simulation; Resveratrol; Stilbenes | 2013 |
Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Colonic Neoplasms; Flow Cytometry; Genistein; Hepatoblastoma; Humans; In Vitro Techniques; Neoplasms; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 2002 |
Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process.
Topics: Biological Availability; Biological Transport, Active; Carrier Proteins; Cell Line; Cell Line, Tumor; Diffusion; Hepatoblastoma; Hepatocytes; Humans; Metabolic Clearance Rate; Resveratrol; Stilbenes; Temperature; Tissue Distribution | 2004 |